Andrew D. Goldberg - 15 Dec 2023 Form 4 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Role
Director
Signature
/s/ Jeffrey Farrow, Attorney-in-Fact
Issuer symbol
TARS
Transactions as of
15 Dec 2023
Net transactions value
+$18,960
Form type
4
Filing time
19 Dec 2023, 18:30:59 UTC
Previous filing
26 Jun 2023
Next filing
14 Jun 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARS Common Stock Purchase $18,960 +1,000 +50% $18.96 3,000 15 Dec 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.